Clinical trials
Respiratory Synctial Virus clinical trials
Below are recruiting respiratory synctial virus clinical trials, each written for real people, not researchers. We’re tracking 5 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06735612Recruiting
RSV and COPD Flare-Ups Study
This study looks at whether RSV (a common respiratory virus) is linked to COPD flare-ups that need urgent care. By testing patients during a flare-up, researchers hope to understand how RSV affects COPD and find better ways to manage it.
BarcelonaAges 50 years+ - NCT06784739Recruiting
COVID-19 immunity study for hospital staff and patients
This study looks at how the immune system responds to COVID-19 in healthcare workers and infected patients at Danderyd Hospital. It aims to understand immunity and help guide future care.
StockholmAges 18 years+ - NCT06775405RecruitingPhase 3
Testing a new RSV treatment for hospitalized babies
This study tests a medicine called AK0529 for babies and toddlers hospitalized with RSV. It aims to see if the drug helps them recover faster and is safe for this age group.
BeijingAges 1 month–2 years - NCT06856967Recruiting
Nirsevimab for RSV in infants under 1 year
This study looks at whether the drug nirsevimab can reduce hospitalizations caused by RSV (a common respiratory virus) in babies under 1 year old. If your baby has a lung infection like bronchiolitis or pneumonia, this trial may help understand how well the medicine works.
Arezzo, ArezzoAges Up to 1 year - NCT07653347Recruiting
Infant RSV immunity study
Researchers want to study how infants naturally fight RSV infections. You and your baby may join if your baby is born in April, May, June, September, October, or November at BC Women's Hospital or a nearby hospital.
Vancouver, British ColumbiaAges Up to 6 months
Hear when a new Respiratory Synctial Virus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for respiratory synctial virus?
- Yes. Clin2 currently lists 5 recruiting respiratory synctial virus studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a respiratory synctial virus trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a respiratory synctial virus trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.